Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Biomedicines, Free Full-Text

Recent advances in graves ophthalmopathy medical therapy: a

Proposal for Standardization of Primary and Secondary Outcomes in

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Recent advances in graves ophthalmopathy medical therapy: a

Effect of dapagliflozin on the rate of decline in kidney function

American Thyroid Association - Our look at the STAGO trial: What's

Statins and type 2 diabetes: genetic studies on target - The Lancet

Rosuvastatin in the Primary Prevention of Cardiovascular Disease

Management of thyroid eye disease: a Consensus Statement by the

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy

Full article: How can we prevent disease relapse in Graves

The effects of lowering LDL cholesterol with simvastatin plus

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and

Efficacy and safety of osilodrostat in patients with Cushing's